Ambry Genetics CEO and leadership

Tom Schoenherr comes to Ambry with more than 20 years of experience in the molecular diagnostics space, most recently as the CCO of Omada Health where he was responsible for driving business growth and increasing market share. He also served in similar roles at Counsyl, Quest Diagnostics, Siemens Healthcare and Abbott Diagnostics. As Ambry’s Chief Commercial Officer, Tom will be responsible for the execution of Ambry’s goto market strategy and will oversee all commercial functions including service, support, sales, marketing, business development, managed care and genetic specialists. Tom earned his BS from Michigan State University and completed his Executive Business Development Program from the University of Notre Dame.

Dr. Tippin Davis joined the company in 2011 and currently serves as the VP for Research and Development where she oversees new clinical product development pipelines as well as clinical research collaborations, including the AmbryShare exome data-sharing project. During her years with the company, Dr. Tippin Davis has served as a Laboratory Technical Director and held many roles including overseeing clinical reporting operations for cancer, cardio, and general genetics, clinical laboratory testing and validations, and served as a member of the diagnostic exome analysis and novel gene discovery team. She received a B.S. in biological sciences and a Ph.D. in Molecular Biology from the University of Southern California as an NIH-NIA fellowship to research defects in DNA replication and repair leading to human disease. She completed her post-doctoral training as an NIH Fellow in Clinical Molecular Genetics at the University of California, Los Angeles/Cedars Sinai Medical Center and is certified by the American Board of Medical Genetics. Prior to joining Ambry, Dr. Tippin Davis was on the faculty at Harbor-UCLA Medical Center in the Division of Medical Genetics where her research focused on the development of novel molecular therapeutics for rare-genetic disorders, including lysosomal storage diseases and inherited forms of colon cancer. Dr. Tippin Davis is a Clinical Genetic Molecular Biologist Scientist in the state of California and currently holds a COQ in the state of New York.

Life science attorney with a clear business focus and 20 years of experience in the biotech/pharmaceutical industry in the US and internationally. Admitted to the bar in California and in Germany.I have advised extensively on regulatory, legal and compliance issues regarding the commercialization of biotech and pharmaceutical products (from ultra-rare disease drugs to specialty blockbusters) as well as diagnostic testing in the US and internationally (in particular EU/EEA, CEE, Russia, Middle East).• Advising Senior Management and Board members on US and international legal and compliance matters• Creating and improving Healthcare Compliance Programs for life science companies • Fraud and Abuse as well as Anti-Kickback advice• FCPA, UK Bribery Act and general anti-corruption advice• Data privacy and IT security (HIPAA, GDPR, CCPA) incl. management of data breach • Access (Pricing, Reimbursement, Patient Support Programs)• Product launch preparation (pre-approval activities) in the US and internationally• Advising marketing and sales teams on regulatory promotion matters (FDA as well as international)• Distribution Agreements for biotech products